The mutagenic and co-mutagenic properties of harman, norharman and of
some of their pharmacologically important derivatives are reviewed. Th
ese compounds do not behave as true mutagens, but rather interact, dir
ectly or indirectly with DNA, leading to various consequences. This un
usual behaviour is most probably related to the particular structure o
f the chemical nucleus common to all beta-carbolines which confers to
the different derivatives the property to interact with various macrom
olecules and enzymatic systems. These interactions are compiled and di
scussed in this review. The alterations, by beta-carbolines, of some i
mportant enzymatic systems, e.g. cytochrome P-450, have been clearly d
emonstrated, yet many discrepancies and contradictions exist so that a
n interpretation of the results and the definition of some common mech
anism appears premature. Since beta-carbolines are widely distributed
in tissues and since they may modify and increase genotoxic and toxic
consequences of other compounds, these interactions need to be clarifi
ed.